Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,516.00    16.00 (1.07%)
Bid:
1,512.00
Ask:
1,522.00
Spread: 10.00 (0.661%)
Market Cap: £291.94m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Blocklisting - Interim Review

27 Aug 2024 10:52

The Biotech Growth Trust PLC - Blocklisting - Interim Review

The Biotech Growth Trust PLC - Blocklisting - Interim Review

PR Newswire

LONDON, United Kingdom, August 27

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

Date: 27 August 2024

 

Name of applicant:

The Biotech Growth Trust PLC

Name of scheme:

General

Period of return:

From:

27 February 2024

To:

26 August 2024

Balance of unallotted securities under scheme(s) from previous return:

3,530,634

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

3,530,634

 

Name of contact:

Katherine Manson - Frostrow Capital LLP

Telephone number of contact:

020 3709 8734

 

 

 



Date   Source Headline
5th May 20261:49 pmPRNNet Asset Value(s)
1st May 20265:32 pmPRNCompliance with Market Abuse Regulation
1st May 20265:20 pmPRNTransaction in Own Shares
1st May 20262:47 pmPRNARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics.
1st May 20261:37 pmPRNNet Asset Value(s)
1st May 20269:48 amPRNTotal Voting Rights
30th Apr 20261:16 pmPRNNet Asset Value(s)
29th Apr 20262:31 pmPRNNet Asset Value(s)
28th Apr 20261:12 pmPRNNet Asset Value(s)
27th Apr 20261:08 pmPRNNet Asset Value(s)
24th Apr 20265:40 pmPRNTransaction in Own Shares
24th Apr 20261:51 pmPRNNet Asset Value(s)
23rd Apr 20261:10 pmPRNNet Asset Value(s)
22nd Apr 20263:05 pmPRNNet Asset Value(s)
21st Apr 202611:45 amPRNNet Asset Value(s)
20th Apr 20262:28 pmPRNNet Asset Value(s)
17th Apr 20265:23 pmPRNTransaction in Own Shares
17th Apr 20262:38 pmPRNNet Asset Value(s)
16th Apr 20261:21 pmPRNNet Asset Value(s)
15th Apr 202612:59 pmPRNNet Asset Value(s)
14th Apr 202612:46 pmPRNNet Asset Value(s)
13th Apr 20261:44 pmPRNNet Asset Value(s)
13th Apr 202610:31 amPRNMonthly Fact Sheet as at 31 March 2026
10th Apr 20265:23 pmPRNTransaction in Own Shares
10th Apr 20262:36 pmPRNNet Asset Value(s)
9th Apr 20261:22 pmPRNNet Asset Value(s)
8th Apr 20263:05 pmPRNNet Asset Value(s)
7th Apr 20261:08 pmPRNNet Asset Value(s)
2nd Apr 20265:01 pmPRNTransaction in Own Shares
2nd Apr 20262:23 pmPRNNet Asset Value(s)
1st Apr 20264:16 pmPRNNet Asset Value(s)
1st Apr 20269:59 amPRNTotal Voting Rights
1st Apr 20267:00 amPRNBiogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc.
31st Mar 202612:42 pmPRNNet Asset Value(s)
30th Mar 202612:43 pmPRNNet Asset Value(s)
27th Mar 20265:16 pmPRNTransaction in Own Shares
27th Mar 20261:35 pmPRNNet Asset Value(s)
26th Mar 20261:08 pmPRNNet Asset Value(s)
25th Mar 20262:08 pmPRNNet Asset Value(s)
24th Mar 202612:34 pmPRNNet Asset Value(s)
23rd Mar 20263:13 pmPRNNet Asset Value(s)
20th Mar 20265:18 pmPRNTransaction in Own Shares
20th Mar 20261:55 pmPRNNet Asset Value(s)
19th Mar 202612:38 pmPRNNet Asset Value(s)
18th Mar 20261:35 pmPRNNet Asset Value(s)
17th Mar 202612:41 pmPRNNet Asset Value(s)
16th Mar 20262:15 pmPRNNet Asset Value(s)
13th Mar 20265:19 pmRNSTransaction in Own Shares
13th Mar 20265:19 pmPRNTransaction in Own Shares
13th Mar 20262:54 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.